GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Convertible Debt (2015 - 2020)

GridAI Technologies' (GRDX) quarterly Convertible Debt came in at $5.3 million in Q2 2020, up 187.69% on a YoY basis from $1.8 million in Q3 2019, and up 76.98% quarter-over-quarter from $3.0 million in Q1 2020.

Analysis

GridAI Technologies (GRDX) Convertible Debt (2015 - 2020) Analysis & Trends

GridAI Technologies (GRDX) has reported Convertible Debt for 6 consecutive years, with $5.3 million the latest figure, recorded in Q2 2020.

  • For the quarter ending Q2 2020, Convertible Debt rose 187.69% year-over-year to $5.3 million; the trailing twelve-month figure through Jun 2020 stood at $5.3 million (up 187.69% YoY), and the FY2019 full-year result was $1.1 million, changed N/A from the prior year.
  • Convertible Debt rose to $5.3 million in Q2 2020 per GRDX's latest filing, from $3.0 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $9.3 million in Q3 2016 and bottomed at $235487.0 in Q1 2018.
  • Historically, Convertible Debt has averaged $2.2 million across 5 years, with a median of $1.4 million in 2019.
  • The sharpest annual moves came in 2017 and 2019: Convertible Debt sank 95.92% in 2017, then surged 633.99% in 2019.
  • Over 5 years, Convertible Debt stood at $9.3 million in 2016, then plunged by 96.21% to $352713.0 in 2017, then dropped by 20.33% to $281024.0 in 2018, then jumped by 283.22% to $1.1 million in 2019, then surged by 390.77% to $5.3 million in 2020.
  • According to Business Quant data, Convertible Debt over the past three periods registered $5.3 million, $3.0 million, and $1.1 million for Q2 2020, Q1 2020, and Q4 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 5.29 Mn
Mar 31, 2020 2.99 Mn
Dec 31, 2019 1.08 Mn
Sep 30, 2019 1.95 Mn
Jun 30, 2019 1.84 Mn
Mar 31, 2019 1.73 Mn
Jun 30, 2018 281,024.00
Mar 31, 2018 235,487.00
Dec 31, 2017 352,713.00
Sep 30, 2017 379,432.00
Jun 30, 2017 645,119.00
Sep 30, 2016 9.30 Mn
Dec 31, 2015 6.15 Mn